Literature DB >> 25445870

The effects of an electronic order set on vancomycin dosing in the ED.

A Brad Hall1, Jennifer Montero2, Jessica Cobian3, Tim Regan4.   

Abstract

OBJECTIVE: The objective of the study was to assess the impact of a computer physician order entry (CPOE) electronic order set on appropriate vancomycin dosing in the emergency department (ED).
METHODS: We conducted a retrospective study examining ED dosing of vancomycin before and after the implementation of an electronic weight-based vancomycin order set. Preimplementation and postimplementation patient records were analyzed between the dates of June 1st and August 31st 2010 for the pre-CPOE group and January 1st to March 31st 2013 for the post-CPOE group. STATISTICAL ANALYSIS: χ(2) analysis, Fisher exact test, and t tests were performed with a 2-sided P value <.05 denoting statistical significance, where appropriate.
RESULTS: A total of 597 patients were included in the study, with 220 in the pre-CPOE group and 377 in the post-CPOE group. The use of the electronic order set resulted in a 21.9% increase (P < .05) in appropriate dosing with 67.4% (254/377) of post-CPOE vancomycin doses considered appropriate vs 45.5% (100/220) in the pre-CPOE group. In critically ill patients, there was a 16.3% increase in appropriate dosing with 44.7% (38/85) in the post-CPOE group compared with 28.4% (19/67) in the pre-CPOE group.
CONCLUSION: The implementation of an electronic order set increased the percentage of ED patients receiving appropriate initial vancomycin doses. The impact of increasing compliance to vancomycin guidelines is in accordance with stewardship principles that promote optimization of antimicrobial dosing based on individual patient characteristics. More studies are needed to assess the relationship between appropriate vancomycin loading doses in the ED and therapeutic outcomes.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25445870     DOI: 10.1016/j.ajem.2014.09.049

Source DB:  PubMed          Journal:  Am J Emerg Med        ISSN: 0735-6757            Impact factor:   2.469


  8 in total

1.  Comparison of Antibiotic Dosing Before and After Implementation of an Electronic Order Set.

Authors:  Kristen R Nichols; Allison L Petschke; Emily C Webber; Chad A Knoderer
Journal:  Appl Clin Inform       Date:  2019-04-03       Impact factor: 2.342

2.  Redesign of computerized decision support to improve antimicrobial prescribing. A controlled before-and-after study.

Authors:  Melissa T Baysari; Jessica Del Gigante; Maria Moran; Indy Sandaradura; Ling Li; Katrina L Richardson; Anmol Sandhu; Elin C Lehnbom; Johanna I Westbrook; Richard O Day
Journal:  Appl Clin Inform       Date:  2017-09-13       Impact factor: 2.342

Review 3.  Optimizing Pharmacokinetics-Pharmacodynamics of Antimicrobial Management in Patients with Sepsis: A Review.

Authors:  Kady Phe; Emily L Heil; Vincent H Tam
Journal:  J Infect Dis       Date:  2020-07-21       Impact factor: 5.226

Review 4.  Weight-based dosing in medication use: what should we know?

Authors:  Sheng-Dong Pan; Ling-Ling Zhu; Meng Chen; Ping Xia; Quan Zhou
Journal:  Patient Prefer Adherence       Date:  2016-04-12       Impact factor: 2.711

5.  Implementation of a Clinical Decision Support Alert for the Management of Clostridium difficile Infection.

Authors:  Sara Revolinski
Journal:  Antibiotics (Basel)       Date:  2015-12-21

6.  The Promising Contributions of Behavioral Economics to Quality Improvement in Health Care.

Authors:  Jack Stevens
Journal:  Pediatr Qual Saf       Date:  2017-05-10

7.  Impact of High Body Weight on Mortality in Critically Ill Patients Receiving Meropenem for Pneumonia.

Authors:  Xiaofang Gao; Liling Liang; Peng Yan
Journal:  Cureus       Date:  2019-12-17

8.  Vancomycin is commonly under-dosed in critically ill children and neonates.

Authors:  Natasha Sosnin; Nigel Curtis; Noel Cranswick; Roberto Chiletti; Amanda Gwee
Journal:  Br J Clin Pharmacol       Date:  2019-08-30       Impact factor: 4.335

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.